Lazertinib-Induced Rhabdomyolysis in a Patient With Non-Small Cell Lung Cancer: A Case Report
이승룡
RESPIROLOGY CASE REPORTS, 202502
2
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial
이승룡
INTEGRATIVE CANCER THERAPIES, 202501
3
Fluid Resuscitation and Initial Management in Patients Presenting with Sepsis in the General Ward
이승룡
LIFE, 202501
4
Rapid Progression of Acute Interstitial Pneumonia in a Patient with Low MDA-5 Antibody Titer
이승룡
AMERICAN JOURNAL OF CASE REPORTS, 202407
5
Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion
이승룡
JOURNAL OF THORACIC DISEASE, 202402
6
Nanoplasmonic Detection of EGFR Mutations Based on Extracellular Vesicle-Derived EGFR-Drug Interaction
이승룡
ACS APPLIED MATERIALS AND INTERFACES, 202402
7
Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)
이승룡
CANCERS, 202312
8
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
이승룡
TRANSLATIONAL LUNG CANCER RESEARCH, 202311
9
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
이승룡
JOURNAL OF THORACIC ONCOLOGY, 202308
10
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial